期刊
MOLECULAR BIOLOGY OF THE CELL
卷 23, 期 11, 页码 2226-2234出版社
AMER SOC CELL BIOLOGY
DOI: 10.1091/mbc.E11-06-0535
关键词
-
类别
资金
- Competence Centers for Excellent Technologies
- Center for Personalized Cancer Medicine
- Austrian Federal Ministry for Transport, Innovation and Technology/Ministry of Economy, Family and Youth (via the Austrian Research Promotion Agency)
- Tiroler Zukunftsstiftung/Standortagentur Tirol
- Kinderkrebshilfe Tirol und Vorarlberg
- SVP-Frauen-Initiative
- Krebshilfe Sudtirol
- Kinderkrebshilfe Sudtirol-Regenbogen
- Tiroler Landeskrankenanstalten
- Tyrolean Cancer Society
- Department of Health Care, Autonomous Province of South Tyrol
Forkhead box O (FOXO) transcription factors control diverse cellular functions, such as cell death, metabolism, and longevity. We analyzed FOXO3/FKHRL1 expression and subcellular localization in tumor sections of neuroblastoma patients and observed a correlation between nuclear FOXO3 and high caspase-8 expression. In neuroblastoma caspase-8 is frequently silenced by DNA methylation. Conditional FOXO3 activated caspase-8 gene expression but did not change the DNA-methylation pattern of regulatory sequences in the caspase-8 gene. Instead, FOXO3 induced phosphorylation of its binding partner ATM and of the ATM downstream target cAMP-responsive element binding protein (CREB), which was critical for FOXO3-mediated caspase-8 expression. Caspase-8 levels above a critical threshold sensitized neuroblastoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced cell death. The DNA-demethylating drug 5-Aza-2-deoxycytidine (5-azadC) induced rapid nuclear accumulation of FOXO3, ATM-dependent CREB phosphorylation, and caspase-8 expression in a FOXO3-dependent manner. This indicates that 5-azadC activates the FOXO3-ATM-CREB signaling pathway, which contributes to caspase-8 expression. The combined data suggest that FOXO3 is activated by 5-azadC treatment and triggers expression of caspase-8 in caspase-8-negative neuroblastoma, which may have important implication for metastasis, therapy, and death resistance of this childhood malignancy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据